Monogram Announces HERmark(TM) Oral Presentation at the 44th ASCO Annual Meeting

                   
redorbit.com     May 16, 2008            

Posted on: Friday, 16 May 2008, 12:00 CDT SOUTH SAN FRANCISCO, Calif., May 16 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. today announced that scientific collaborators will present results on HERmark(TM), the company's novel oncology assay, as a means to measure HER2 and predict response... [read full story]                

Full Coverage

Monogram Announces HERmark(TM) Oral Presentation at the 44th ASCO Annual Meeting (PR Newswire)

yahoo.com     May 16, 2008          

Monogram Biosciences, Inc. today announced that scientific collaborators will present results on HERmark, the company's novel oncology assay, as a means to measure HER2 and predict response to Herceptin® in patients with metastatic breast cancer at the upcoming 44th ASCO Annual Meeting taking...                

comments